Gains, Gains, Gains! – Wednesday review, April 29

Gains, Gains, Gains! – Wednesday review, April 29

After a disappointing Consumer Confidence report, the market rejoiced once Gilead announced that it is one step closer to a successful treatment against the novel virus.

The US

Gilead’s statement put Wall Street to work. All benchmarks rallied. USA30 gained 2.09%, while USA500 rose 2.54%. TECH100 added 3.33%.

Oil was up 14.3% to trade at $17.35 per barrel. Brent Oil gained 10.3% to $24.87.

Gold stood still at $1, 710.86 per ounce.

ICE was at 99.584.


Asia and Australia

Good news travels fast across the ocean. The successful trial and the slowing increase in the number of cases impacted the market. Japan225 jumped 2.8%, reaching a seven-week high. Australia's ASX gained 2.7%.

USD/JPY traded higher at 106.56.

AUD/USD was $0.6557.


Europe

In Europe, besides the hype that Gilead created, stocks gained pending the ECB meeting. Europe expects a new stimulus to keep the economy afloat. Europe50 and UK100 gained more than 1% each. Germany30 added 2.89%, while France40 went up 2.22%.

EUR/USD traded higher at $1.0862.


See the difference when trading with CAPEX.com by accessing elite features:

  • Stellar custom service
  • Powerful WebTrader platform and mobile app
  • High-end integrated trading tools
  • Full license and regulation from top regulators


Sources: cnbc.com, investing.com, reuters.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation. Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.


La información presentada aquí está preparada por CAPEX.com y no pretende constituir un asesoramiento de inversión. La información aquí se proporciona como una comunicación general de marketing con propósitos solo de información, y como tal, no se han preparado de acuerdo con los requisitos legales diseñados para promover la independencia de un estudio de inversión, y no está sujeto a ninguna prohibición para hacer frente con antelación a la diseminación de los análisis de inversión.

Los usuarios / lectores no deben confiar únicamente en la información presentada aquí y deben hacer su propia investigación / análisis leyendo también la investigación subyacente real. El contenido adjunto es genérico y no tiene en cuenta las circunstancias personales, la experiencia de inversión o la situación financiera actual.

Por lo tanto, Key Way Investments Ltd no aceptará ninguna responsabilidad por las pérdidas de los comerciantes debido al uso y el contenido de la información presentada en este documento. El rendimiento pasado no es un indicador confiable de resultados futuros.